RT Journal Article
SR Electronic
T1 COPD with elevated sputum group 2 innate lymphoid cells is characterized by severe disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.21.23298837
DO 10.1101/2023.11.21.23298837
A1 Flayer, Cameron H.
A1 Linderholm, Angela L.
A1 Ge, Moyar Q.
A1 Juarez, Maya
A1 Franzi, Lisa
A1 Tham, Tina
A1 Teuber, Melissa
A1 Liao, Shu-Yi
A1 Schivo, Michael
A1 Kuhn, Brooks
A1 Zeki, Amir
A1 Haczku, Angela
YR 2024
UL http://medrxiv.org/content/early/2024/04/03/2023.11.21.23298837.abstract
AB Rationale Pulmonary innate immune cells play a central role in the initiation and perpetuation of chronic obstructive pulmonary disease (COPD), however the precise mechanisms that orchestrate the development and severity of COPD are poorly understood.Objectives We hypothesized that the recently described family of innate lymphoid cells (ILCs) play an important role in COPD.Methods Subjects with COPD and healthy controls were clinically evaluated, and their sputum samples were assessed by flow cytometry. A mouse model of spontaneous COPD [genetically deficient in surfactant protein-D (SP-D-/-)] and ozone (O3) exposure were used to examine the mechanism by which lack of functional SP-D may skew ILC2s to produce IL-17A in combination with IL-5 and IL-13, leading to a mixed inflammatory profile and more severe disease.Measurements and Main Results COPD was characterized by poor spirometry, sputum inflammation, and the emergence of sputum GATA3+ ILCs (ILC2s), but not T-bet+ ILCs (ILC1s) nor RORγt+ ILCs (ILC3s). COPD subjects with elevated sputum ILC2s (the ILC2high group) had worse spirometry and sputum neutrophilia and eosinophilia than healthy and ILC2low subjects. This was associated with the presence of dual-positive IL-5+IL-17A+ and IL-13+IL-17A+ ILCs and nonfunctional SP-D in the sputum in ILC2high subjects. SP-D-/- mice showed spontaneous airway neutrophilia. Lack of SP-D in the mouse lung licensed ILC2s to produce IL-17A, which was dose-dependently inhibited by recombinant SP-D. SP-D-/- mice showed enhanced susceptibility to O3-induced airway neutrophilia, which was associated with the emergence of inflammatory IL-13+IL-17A+ ILCs.Conclusions We report that the presence of sputum ILC2s predicts the severity of COPD, and unravel a novel pathway of IL-17A plasticity in lung ILC2s, prevented by the immunomodulatory protein SP-D.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Tobacco-Related Disease Research Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of California, Davis gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are available upon reasonable request to the authors.COPDChronic Obstructive Pulmonary DiseaseSP-DSurfactant Protein-DILCInnate Lymphoid CellILC1Group 1 Innate Lymphoid CellILC2Group 2 Innate Lymphoid CellILC3Group 3 Innate Lymphoid CellFEV1Forced Expiratory Volume in one secondFVCForced Vital CapacityGOLDGlobal Initiative for Chronic Obstructive Lung DiseasePFTPulmonary Function TestingmMRCModified Medical Research Council scaleCATCOPD Assessment TestMPMacrophage/monocyteLCLymphocyteNPNeutrophilEPEosinophilWTC57BL/6 Wild-typeBALBronchoalveolar Lavage FluidO3OzonePBSPhosphate-buffed SalinerSP-DMouse Recombinant SP-DSpO2Specific Oxygen